News Focus
News Focus
Followers 1
Posts 84
Boards Moderated 0
Alias Born 02/09/2023

Re: MeteoricChimera43 post# 8472

Friday, 09/27/2024 9:49:10 AM

Friday, September 27, 2024 9:49:10 AM

Post# of 9090
I agree with your idea.
Korean toxin companies has been traded and acquired at a good price from global private equity fund in the M&A market i.e. Hugel.
Revance has to get much higher price in the M&A market. IMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y